|
1
|
Libson S and Lippman M: A review of
clinical aspects of breast cancer. Int Rev Psychiatry. 26:4–15.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Criscitiello C, André F, Thompson AM, De
Laurentiis M, Esposito A, Gelao L, Fumagalli L, Locatelli M,
Minchella I, Orsi F, et al: Biopsy confirmation of metastatic sites
in breast cancer patients: Clinical impact and future perspectives.
Breast Cancer Res. 16:2052014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma RR, Pollock K, Hubel A and McKenna
D: Mesenchymal stem or stromal cells: A review of clinical
applications and manufacturing practices. Transfusion.
54:1418–1437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kupcova Skalnikova H: Proteomic techniques
for characterisation of mesenchymal stem cell secretome. Biochimie.
95:2196–2211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Akhurst RJ and Hata A: Targeting the TGFβ
signalling pathway in disease. Nat Rev Drug Discov. 11:790–811.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li B, Wen G, Zhao Y, Tong J and Hei TK:
The role of TGFBI in mesothelioma and breast cancer: Association
with tumor suppression. BMC Cancer. 12:2392012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brown DI and Griendling KK: Regulation of
signal transduction by reactive oxygen species in the
cardiovascular system. Circ Res. 116:531–549. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krstić J, Trivanović D, Mojsilović S and
Santibanez JF: Transforming growth factor-beta and oxidative stress
interplay: Implications in tumorigenesis and cancer progression.
Oxid Med Cell Longev. 2015:6545942015. View Article : Google Scholar
|
|
10
|
Jozkowicz A, Was H and Dulak J: Heme
oxygenase-1 in tumors: Is it a false friend? Antioxid Redox Signal.
9:2099–2117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gueron G, Giudice J, Valacco P, Paez A,
Elguero B, Toscani M, Jaworski F, Leskow FC, Cotignola J, Marti M,
et al: Heme-oxygenase-1 implications in cell morphology and the
adhesive behavior of prostate cancer cells. Oncotarget.
5:4087–4102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cherrington JM, Strawn LM and Shawver LK:
New paradigms for the treatment of cancer: The role of
anti-angiogenesis agents. Adv Cancer Res. 79:1–38. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen HW, Chao CY, Lin LL, Lu CY, Liu KL,
Lii CK and Li CC: Inhibition of matrix metalloproteinase-9
expression by docosahexaenoic acid mediated by heme oxygenase 1 in
12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 human breast
cancer cells. Arch Toxicol. 87:857–869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zavadil J, Cermak L, Soto-Nieves N and
Böttinger EP: Integration of TGF-beta/Smad and Jagged1/Notch
signalling in epithelial-to-mesenchymal transition. EMBO J.
23:1155–1165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vincent T, Neve EP, Johnson JR, Kukalev A,
Rojo F, Albanell J, Pietras K, Virtanen I, Philipson L, Leopold PL,
et al: A SNAIL1-SMAD3/4 transcriptional repressor complex promotes
TGF-beta mediated epithelial-mesenchymal transition. Nat Cell Biol.
11:943–950. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang KH, Tian HY, Gao X, Lei WW, Hu Y,
Wang DM, Pan XC, Yu ML, Xu GJ, Zhao FK, et al: Ferritin heavy
chain-mediated iron homeostasis and subsequent increased reactive
oxygen species production are essential for epithelial-mesenchymal
transition. Cancer Res. 69:5340–5348. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lim SO, Gu JM, Kim MS, Kim HS, Park YN,
Park CK, Cho JW, Park YM and Jung G: Epigenetic changes induced by
reactive oxygen species in hepatocellular carcinoma: Methylation of
the E-cadherin promoter. Gastroenterology. 135:2128–2140.
2140.e1–2140.e8. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lochter A, Galosy S, Muschler J, Freedman
N, Werb Z and Bissell MJ: Matrix metalloproteinase stromelysin-1
triggers a cascade of molecular alterations that leads to stable
epithelial-to-mesenchymal conversion and a premalignant phenotype
in mammary epithelial cells. J Cell Biol. 139:1861–1872. 1997.
View Article : Google Scholar
|
|
19
|
Baum B and Georgiou M: Dynamics of
adherens junctions in epithelial establishment, maintenance, and
remodeling. J Cell Biol. 192:907–917. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Herszterg S, Leibfried A, Bosveld F,
Martin C and Bellaiche Y: Interplay between the dividing cell and
its neighbors regulates adherens junction formation during
cytokinesis in epithelial tissue. Dev Cell. 24:256–270. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tomita K, van Bokhoven A, van Leenders GJ,
Ruijter ET, Jansen CF, Bussemakers MJ and Schalken JA: Cadherin
switching in human prostate cancer progression. Cancer Res.
60:3650–3654. 2000.PubMed/NCBI
|
|
22
|
Sawada K, Mitra AK, Radjabi AR, Bhaskar V,
Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A,
Kenny HA, et al: Loss of E-cadherin promotes ovarian cancer
metastasis via alpha 5-integrin, which is a therapeutic target.
Cancer Res. 68:2329–2339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang B, Peng ZH, Yu PW, Yu G and Qian F:
Expression and significance of Cx43 and E-cadherin in gastric
cancer and metastatic lymph nodes. Med Oncol. 28:502–508. 2011.
View Article : Google Scholar
|
|
24
|
Chao YL, Shepard CR and Wells A: Breast
carcinoma cells re-express E-cadherin during mesenchymal to
epithelial reverting transition. Mol Cancer. 9:1792010. View Article : Google Scholar : PubMed/NCBI
|
